Professor David Harris

Professor
Medicine, Westmead Clinical School
Westmead Millennium Institute for Medical Research

Telephone +61 2 9845 8938
Fax +61 2 9891 3749

Map

Research interests

The prevention and management of chronic kidney disease (CKD), as well as the management of patients with end stage kidney disease by peritoneal and haemodialysis. Laboratory research interests focus on progression of CKD, most recently the use of cellular and other novel approaches to slow progression.

Selected grants

2014

  • Defining the role of the major subsets of renal mononuclear phogocytes; Harris D, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Therapeutic potential of peritoneal mononuclear phagocytes from peritoneal dialysis patients; Wang Y, Harris D, Yi S; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Randomised controlled trial to prevent Kidney Disease due to ADPKD; Rangan G, Harris D; DVC Research/Bridging Support Grant.

2013

  • Differentiation of pro-fibrotic from anti-inflammatory effects of TGF-B in kidney fibrosis by targeting B-catenin; Harris D, Zheng G; National Health and Medical Research Council (NHMRC)/Project Grants.
  • CKD-FIX: a randomised, controlled trial of allopurinol in the slowing of kidney disease progression; Johnson D, Harris D, Faull R, Palmer S, Boudville N, Badve S, Rangan G, Kanellis J, Walker R, Brown F; National Health and Medical Research Council (NHMRC)/Project Grants.

2012

  • Targeting Beta-catenin in Kidney Fibrosis; Harris D, Zheng G; DVC Research/Bridging Support Grant.
  • Small Rodent Airlaw Caging System; George J, O'Connell P, Cunningham A, Hawthorne W, Little D, Djordjevic J, Harris D, Hebbard L, Liddle C, Fletcher J; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2010

  • The BD Influx High Speed Cell Sorter; Kefford R, Cunningham A, Bendall L, Clarke C, Harris D, Alexander S, Tam P, Sorrell T, Iredell J, Bryan T, Rizos H, Wang Y, Hebbard L; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Vitamin D3 receptor signalling to prevent kidney failure due to polycystic kidney disease; Rangan G, Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Optimising the therapeutic efficacy of anti-inflammatory macrophages for use in chronic kidney diseases; Wang Y, Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Preventing Kidney Fibrosis By Targeting Matrix Metalloproteinase-9 in Chronic Kidney Disease; Harris D, Zheng G; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Gamm-Delta Tregs, CD8 Tregs and selected natural Tregs to treat renal injury; Alexander S, Harris D, Wang Y, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • DNA vaccination using chemokine and costimulatory pathways as a treatment for chronic kidney disease; Harris D, Alexander S, Wang Y, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Preventing kidney fibrosis by targeting MMP-9 in Cronic Kidney Diseases; Harris D; DVC Research/Bridging Support Grant.
  • IL-21 and its associated intracellular signalling molecule, JAK3, are important in the development of crescentic glomerulonephritis and expression of urinary and haematologic biomarkers provide clinically useful advances in monitoring disease activity; Phoon R, Harris D; Royal Australasian College of Physicians/Research Support.

2008

  • Modified DNA vaccination using chemokine and costimulatory pathways as a treatment for chronic kidne; Harris D; University of Sydney/Bridging Support.
  • Bridging Grant; Harris D; Westmead Research Foundation/Westmead Millennium Foundation.

2007

  • Treatment of Diverse Renal Diseases with Regulatory Cells; Harris D, Alexander S, Wang Y, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Initiating Dialysis Early and Late Trial; Pollock C, Harris D, Cooper B; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Loss of E-cadherin in distal tubule cells as a common pathway for cyst formation in polycystic kidney disease; Rangan G, Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Kidney Injury as a determinant of macrophage phenotype and efficacy for treating chronic kidney disease (CKD); Wang Y, Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.

2006

  • E-Cadherin as the key molecule in renal epithelial-mesenchymal transition and fibrosis; Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.

2004

  • Costimulation in progressive non-immune tubulointerstitial renal disease; Harris D, Alexander S, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • Centre of clinical research excellence in renal medicine; Walker R, Atkins R, Craig J, Chadban S, Irwig L, Harris D, O'Connell P, Walker R, Chadban S, Atkins R, Irwig L; National Health and Medical Research Council (NHMRC)/Centre of Clinical Research Excellence.
  • Area Health Service contributions to research only staff; Harris D, Russell R; Sydney South West Area Health Service/Contributions to research staff.

2002

  • Effector and regulatory interstitial inflammatory cells in chronic proteinuric renal disease; Harris D, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The IDEAL trial - initiating dialysis early and late; Craig J, Harris D, Pollock C, Rodgers A; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Initiating dialysis early and late. An economic and quality of life analysis; Pollock C, Harris D; AHMAC/SCRIF/Research Grant.

2000

  • Modification of tubule cell cytokines regulating interstitial inflammation in chronic proteinuric renal disease; Harris D, Wang Y; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Tubular cell chemokine production in proteinuric renal disease; Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Mechanisms and relative toxicity of urinary proteins in causing tubular cell injury; Harris D; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Books

  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2012). Pocket Guide to Clinical Dialysis. Sydney, Australia: McGraw Hill.
  • Harris, D. (2007). Clinical Cases in Kidney Disease. Australia: McGraw Hill.
  • Field, M., Pollock, C., Harris, D. (2001). The Renal System. United States: Elsevier - Health Sciences Division.

Edited Books

  • Harris, D. (2008). Clinical Cases in Kidney Disease. Australia: McGraw Hill.
  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2005). Basic Clinical Dialysis. Sydney: McGraw-Hill, Medical Pub. Division.

Book Chapters

  • Tian, X., Dong, Y., Zhang, J., Wang, H., Xie, J., Niu, B., Harris, D., Zheng, G. (2013). Beta-Catenin and Kidney Fibrosis. In Abel Braunfeld, Gabriel R. Mirsky (Eds.), Beta-Catenin: Structure, Function and Clinical Significance, (pp. 63-88). New York: Nova Science Publishers.
  • Zheng, G., Zhang, J., Tan, T., Hsu, T., Tian, X., Niu, B., Harris, D. (2012). Matrix Metalloproteinases (MMPs) in Renal Fibrosis. In Namae Oshiro and Eiko Miyagi (Eds.), Matrix Metalloproteinases: Biology, Functions and Clinical Implications, (pp. 169-186). New York: Nova Science Publishers, Inc.
  • Becker, G., Collins, J., Harris, D. (2012). Renal Disease in the Oceania Region. In M Taal, G Chertow, P Marsden, K Skorecki, A Yu and B Brenner (Eds.), Brenner & Rector's The Kidney, (pp. 2803-2821). Philadelphia: Saunders Elsevier.
  • Collins, J., Cooper, B., Branley, P., Bulfone, L., Craig, J., Fraenkel, M., Harris, A., Johnson, D., Kesselhut, J., Li, J., Tiller, D., Pollock, C., et al (2011). Outcomes of patients with planned initiation of hemodialysis in the IDEAL Trial. In Ronco C; Rosner M (Eds.), Contributions to Nephrology: Hemodialysis New Methods and Future Technology, (pp. 1-9). Basel, Switzerland: S. Karger AG.
  • Lee, V., Cao, Q., Wang, Y., Harris, D. (2011). Role of Macrophages in Renal Injury,Repair and Regeneration. In Michael S. Goligorsky (Eds.), Regenerative Nephrology, (pp. 125-139). USA: Elsevier.
  • Succar, L., Harris, D., Rangan, G. (2011). Role of the Mammalian Target of Rapamycin (mTOR) Signalling Pathway in Podocytes in Glomerular Disease. In Sharma S. Prabhakar (Eds.), An Update on Glomerulopathies – Etiology and Pathogenesis, (pp. 183-202). Rijeka, Croatia: InTech Publishers.
  • Lee, V., Harris, D., Anderson, R., Schrier, R. (2007). Acute Renal Failure. In Robert W. Schrier (Eds.), Diseases of the Kidney and Urinary Tract, (pp. 986-1034). Philadelphia: Lippincott Williams & Wilkins.

Journals

  • Zheng, D., Wen, L., Li, C., Peng, A., Cao, Q., Wang, Y., Harris, D. (2014). Adoptive transfer of bone marrow dendritic cells failed to localize in the renal cortex and to improve renal injury in adriamycin nephropathy. Nephron Experimental Nephrology, 126(1), 8-15. [More Information]
  • Harris, D., Feehally, J. (2014). Age, CKD and other kidney messages. Medical Journal of Australia, 200(4), 191-192. [More Information]
  • Wong, M., Pollock, C., Cooper, B., Branley, P., Collins, J., Craig, J., Kesselhut, J., Luxton, G., Pilmore, A., Harris, D., et al (2014). Association between GFR estimated by multiple methods at dialysis commencement and patient survival. Clinical journal of the American Society of Nephrology, 9(1), 135-142. [More Information]
  • Bose, B., Badve, S., Hiremath, S., Boudville, N., Brown, F., Cass, A., de Zoysa, J., Fassett, R., Faull, R., Harris, D., Perkovic, V., Rangan, G., et al (2014). Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation, 29(2), 406-413. [More Information]
  • Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, C., Wang, X., Lee, V., Wang, Y., Wang, Y., Zheng, G., Tan, T., Harris, D., et al (2014). Failed renoprotection by alternatively activated macrophages from bone marrow due to proliferation-dependent phenotype switch in vivo. Kidney International, 85(4), 794-806. [More Information]
  • Feehally, J., Couser, W., Dupuis, S., Finkelstein, F., Harden, P., Harris, D., Lameire, N., Naicker, S., Remuzzi, G., Segantini, L., et al (2014). Nephrology in developing countries: the ISN's story. The Lancet, 383(9925), 1271-1272. [More Information]
  • Wang, Y., Wang, Y., Wang, Y., Zheng, G., Tan, T., Lee, S., Zhang, J., Zhang, G., Hu, M., Wang, C., Cao, Q., Zhao, Y., Harris, D., et al (2014). Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis. International Journal of Clinical and Experimental Pathology, 7(1), 38-47.
  • Gopinath, B., Harris, D., Flood, V., Burlutsky, G., Mitchell, P. (2013). A better diet quality is associated with a reduced likelihood of CKD in older adults. Nutrition Metabolism and Cardiovascular Diseases, 23(10), 937-943. [More Information]
  • Zhou, J., Wang, Y., Harris, D., Medbury, H., Williams, H., Durkan, A., Alexander, S., Lee, V., Tan, T., Hu, M., et al (2013). Adenine-induced Chronic Kidney Disease Is Associated with Arterial Macrophage Infiltration and Medial Vascular Calcification. Nephrology, 18(Supp 1), 52-52.
  • Wang, Y., Sawyer, A., Zhou, J., Zhang, G., Wang, Y., Hu, M., Roberts, V., Dwyer, K., Harris, D., Alexander, S. (2013). Analysis of Linkage of P2x7r to Balb/C Associated Kidney Injury in the Adriamycin Murine Model in F2 Mice. Nephrology, 18(Supp. 1), 60-60.
  • Tian, X., Zhang, J., Tan, T., Lyons, G., Zhao, H., Niu, B., Lee, S., Tsatralis, T., Zhao, Y., Wang, Y., Cao, Q., Wang, C., Wang, Y., Lee, V., Zheng, G., Harris, D., et al (2013). Association of beta catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF- beta1. Journal of Cell Science, 126(1), 67-76. [More Information]
  • Wang, C., Yu, X., Cao, Q., Wang, Y., Zheng, G., Tan, T., Zhao, H., Zhao, Y., Wang, Y., Harris, D. (2013). Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunology, 14(1), 1-10. [More Information]
  • Rangan, G., Schwensen, K., Foster, S., Korgaonkar, M., Peduto, A., Harris, D. (2013). Chronic effects of dietary Vitamin D deficiency without increased calcium supplementation on the progression of experimental polycystic kidney disease. American Journal of Physiology: Renal Physiology (Print), 305(4), F574-F582. [More Information]
  • Zhou, J., Wang, Y., Lee, V., Zhang, G., Medbury, H., Williams, H., Wang, Y., Harris, D., Alexander, S., Durkan, A. (2013). Cx3cr1-dec205 dc-targeted dna Vaccine Induces Specific Antibodies and Limits Atherosclerosis and Macrophage Infiltration in the apo-e Knockout Mouse Model of Atherosclerosis. Nephrology, 18(Supp. 1), 16-16.
  • Wang, Y., Zhou, J., Wang, Y., Watson, D., Zhang, G., Hu, M., Wu, H., Zheng, G., Wang, Y., Durkan, A., Harris, D., Alexander, S. (2013). Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease. International Journal of Clinical and Experimental Pathology, 6(3), 326-333. [More Information]
  • Rosansky, S., Cancarini, G., Clark, W., Eggers, P., Germaine, M., Glassock, R., Goldfarb, D., Harris, D., Hwang, S., Imperial, E., et al (2013). Dialysis Initiation: What's the Rush? Seminars in Dialysis, 26(6), 650-657. [More Information]
  • Medbury, H., James, V., Ngo, J., Hitos, K., Wang, Y., Harris, D., Fletcher, J. (2013). Differing association of macrophage subsets with atherosclerotic plaque stability. International Angiology, 32(1), 74-84. [More Information]
  • Lu, J., Cao, Q., Zheng, D., Sun, Y., Wang, C., Yu, X., Wang, Y., Lee, V., Zheng, G., Tan, T., Wang, X., Harris, D., Wang, Y., et al (2013). Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney International, 84(4), 745-755. [More Information]
  • Wang, Y., Wang, Y., Wang, Y., Zheng, G., Zhang, G., Zhou, J., Tan, T., Cao, Q., Hu, M., Watson, D., Wu, H., Zheng, D., Wang, C., Harris, D., et al (2013). DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats. Kidney International, 83(2), 223-232. [More Information]
  • Whalley, G., Marwick, T., Doughty, R., Cooper, B., Johnson, D., Pilmore, A., Harris, D., Pollock, C., Collins, J. (2013). Effect of Early Initiation of Dialysis on Cardiac Structure and Function: Results From the Echo Substudy of the IDEAL Trial. American Journal of Kidney Diseases, 61(2), 262-270. [More Information]
  • Cao, Q., Wang, X., Wang, C., Lee, V., Ye, Q., Zheng, G., Zhao, Y., Alexander, S., Wang, Y., Harris, D. (2013). Kidney Cd103+ Dcs Exacerbate Renal Injury Through Activating Cd8+ T Cells in Adriamycin Nephropathy. Nephrology, 18(Supp. 1), 24-24.
  • Tan, T., Zheng, G., Hsu, T., Lee, S., Zhang, J., Zhao, Y., Tian, X., Wang, Y., Wang, Y., Cao, Q., Wang, Y., Lee, V., Wang, C., Zheng, D., Alexander, S., Harris, D., et al (2013). Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage. Laboratory Investigation, 93(4), 434-449. [More Information]
  • Zhao, H., Dong, Y., Tian, X., Tan, T., Liu, Z., Zhao, Y., Zhang, Y., Harris, D., Zheng, G. (2013). Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World Journal of Nephrology, 2(3), 84-89. [More Information]
  • Wang, Y., Wang, C., Cao, Q., Ye, Q., Zheng, G., Alexander, S., Jones, D., Harris, D. (2013). Midkine Antibodies Prevent Renal Injury in Adriamycin Nephropathy. Nephrology, 18(Supp. 1), 59-59.
  • Zhao, Y., Zhao, H., Zhang, Y., Zhang, J., Tsatralis, T., Cao, Q., Wang, Y., Wang, Y., Zheng, G., Harris, D. (2013). Notch Signaling Mediates Mmp-9-Dependent Endothelialmesenchymal Transition Downstream of Tgf-B in Human Renal Glomerular Endothelial Cells. Nephrology, 18(Supp. 1), 52-52.
  • Cao, Q., Wang, Y., Harris, D. (2013). Pathogenic and protective role of macrophages in kidney disease. American Journal of Physiology: Renal Physiology (Print), 305(1), F3-F11. [More Information]
  • Ta, M., Rao, P., Korgaonkar, M., Foster, S., Peduto, A., Harris, D., Rangan, G. (2013). Pyrrolidine Dithiocarbamate Attenuates Kidney Enlargement in Experimental Polycystic Kidney Disease. Nephrology, 18(Supp. 1), 37-37.
  • Rangan, G., Harris, D. (2013). Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD. Current Hypertension Reviews, 9(2), 115-120. [More Information]
  • Gopinath, B., Harris, D., Wall, J., Kifley, A., Mitchell, P. (2013). Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas, 75(2), 159-164. [More Information]
  • Forbes, J., Harris, D., Cooper, M. (2013). Report on ISN Forefronts, Melbourne, Australia, 4-7 October 2012: tubulointerstitial disease in diabetic nephropathy. Kidney International, 84(4), 653-656. [More Information]
  • Ta, M., Harris, D., Rangan, G. (2013). Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology, 18(5), 317-330. [More Information]
  • Wong, M., Pollock, C., Cooper, B., Branley, P., Collins, J., Craig, J., Pilmore, A., Kesselhut, J., Harris, D., Johnson, D. (2013). The Association Between Glomerular Filtration Rate Estimated by Multiple Methods at Dialysis Commencement and Patient Survival in the Ideal Trial. Nephrology, 18(Supp. 1), 17-17.
  • Zhang, G., Zhang, J., Zhang, H., Tsatralis, T., Hu, M., Wang, Y., Cao, Q., Wang, Y., Zheng, G., Harris, D. (2013). The Role of B-Catenin in TGF-B1-Induced Foxp3 Expression and Treg Induction. Nephrology, 18(Supp. 1), 59-59.
  • Lee, V., Wang, Y., Harris, D. (2013). The Role of the Immune System in the Pathogenesis of Hypertension. Current Hypertension Reviews, 9(1), 76-84. [More Information]
  • Gopinath, B., Harris, D., Burlutsky, G., Mitchell, P. (2013). Use of Community Support Services and Activity Limitations Among Older Adults With Chronic Kidney Disease. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 68(6), 741-747. [More Information]
  • Wang, Y., Zhang, G., Hu, M., Polhill, T., Sawyer, A., Zhou, J., Saito, M., Watson, D., Wu, H., Wang, Y., Wang, X., Wang, Y., Harris, D., Alexander, S. (2012). CD8+ Regulatory T Cells Induced by T Cell Vaccination Protect Against Autoimmune Nephritis. Journal of the American Society of Nephrology, 23(6), 1058-1067. [More Information]
  • Zhou, J., Wang, Y., Lee, V., Phoon, R., Zhang, G., Wang, Y., Tan, T., Hu, M., Wang, D., Saito, M., Harris, D., Durkan, A., et al (2012). DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration. International Journal of Clinical and Experimental Medicine, 5(1), 24-33. [More Information]
  • Johnson, D., Wong, M., Cooper, B., Branley, P., Bulfone, L., Collins, J., Craig, J., Fraenkel, M., Harris, A., Kesselhut, J., Tiller, D., Harris, D., Pollock, C., et al (2012). Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the ideal trial. Peritoneal Dialysis International, 32(6), 595-604. [More Information]
  • Polhill, T., Zhang, G., Hu, M., Sawyer, A., Zhou, J., Saito, M., Webster, K., Wang, Y., Wang, Y., Grey, S., Harris, D., Alexander, S., Wang, Y., et al (2012). IL-2/IL-2Ab Complexes Induce Regulatory T Cell Expansion and Protect against Proteinuric CKD. Journal of the American Society of Nephrology, 23(8), 1303-1308. [More Information]
  • Zheng, D., Cao, Q., Lee, V., Wang, Y., Zheng, G., Wang, Y., Tan, T., Wang, C., Alexander, S., Harris, D., Wang, Y. (2012). Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease. Kidney International, 81(9), 892-902. [More Information]
  • Wang, Y., McRae, J., Robson, S., Cowan, P., Zhang, G., Hu, M., Polhill, T., Wang, Y., Zheng, G., Wang, Y., Lee, V., Harris, D., Alexander, S., et al (2012). Regulatory T cells participate in CD39-mediated protection from renal injury. European Journal of Immunology, 42(9), 2441-2451. [More Information]
  • Myint, T., Cooper, B., Pollock, C., Harris, D. (2012). Starting Dialysis Early: No Survival, Quality of Life, or Cost Advantages. Seminars in Dialysis, 25(5), 522-523. [More Information]
  • Harris, D., Dupuis, S., Couser, W., Feehally, J. (2012). Training nephrologists from developing countries: does it have a positive impact? Kidney International Supplements, 2, 275-278. [More Information]
  • Pollock, C., Cooper, B., Harris, D. (2012). When should we commence dialysis? The story of a lingering problem and today's scene after the IDEAL study. Nephrology, Dialysis, Transplantation, 27(6), 2162-2166. [More Information]
  • Harris, D. (2011). A new admiral for the flagship. Kidney International, 80(9), 899-899. [More Information]
  • Lee, V., Harris, D. (2011). Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology, 16(1), 30-38. [More Information]
  • Li, P., Chow, K., Matsuo, S., Yang, C., Jha, V., Becker, G., Chen, N., Sharma, S., Chittinandana, A., Chowdhury, S., Harris, D., et al (2011). Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology, 16(7), 633-641. [More Information]
  • Gopinath, B., Harris, D., Flood, V., Burlutsky, G., Brand-Miller, J., Mitchell, P. (2011). Carbohydrate Nutrition Is Associated with the 5-Year Incidence of Chronic Kidney Disease 1–3. The Journal of Nutrition, 141(3), 433-439. [More Information]
  • Gopinath, B., Harris, D., Flood, V., Burlutsky, G., Mitchell, P. (2011). Consumption of long-chain n-3 PUFA, α-linolenic acid and fish is associated with the prevalence of chronic kidney disease. British Journal of Nutrition, 105(9), 1361-1368. [More Information]
  • Harris, A., Cooper, B., Li, J., Bulfone, L., Branley, P., Collins, J., Craig, J., Fraenkel, M., Johnson, D., Kesselhut, J., Tiller, D., Pollock, C., Harris, D., et al (2011). Cost-effectiveness of initiating dialysis early: A randomized controlled trial. American Journal of Kidney Diseases, 57(5), 707-715. [More Information]
  • Tian, X., Liu, Z., Niu, B., Zhang, J., Tan, T., Lee, S., Zhao, Y., Harris, D., Zheng, G. (2011). E-cadherin/β-catenin complex and the epithelial barrier. Journal of Biomedicine and Biotechnology, 2011, 567305-1-567305-6. [More Information]
  • Schwensen, K., Burgess, J., Graf, N., Alexander, S., Harris, D., Phillips, J., Rangan, G. (2011). Early Cyst Growth Is Associated with the Increased Nuclear Expression of Cyclin D1/Rb Protein in an Autosomal-Recessive Polycystic Kidney Disease Rat Model. Nephron Experimental Nephrology, 117(4), e93-e103. [More Information]
  • Cao, Q., Wang, C., Zheng, D., Wang, Y., Lee, V., Wang, Y., Zheng, G., Tan, T., Yu, D., Alexander, S., Harris, D., Wang, Y. (2011). IL-25 Induces M2 Macrophages and Reduces Renal Injury in Proteinuric Kidney Disease. Journal of the American Society of Nephrology, 22(7), 1229-1239. [More Information]
  • Harris, A., Pollock, C., Harris, D. (2011). In Reply to ‘Regarding Early Initiation of Dialysis’. American Journal of Kidney Diseases, 58(3), 492-492. [More Information]
  • Harris, D., Gopinath, B., Mitchell, P. (2011). Is the link between chronic kidney disease and hearing loss in older patients likely to be causal? Aging Health, 7(1), 5-7.
  • Cao, Q., Zheng, D., Wang, Y., Harris, D. (2011). Macrophages and Dendritic Cells for Treating Kidney Disease. Nephron Experimental Nephrology, 117(3), e47-e52. [More Information]
  • Wang, Y., Harris, D. (2011). Macrophages in renal disease. Journal of the American Society of Nephrology, 22(1), 21-27. [More Information]
  • Sun, Y., Yu, H., Zheng, D., Cao, Q., Wang, Y., Harris, D., Wang, Y. (2011). Sudan Black B Reduces Autofluorescence in Murine Renal Tissue. Archives of Pathology and Laboratory Medicine, 135(10), 1335-1342. [More Information]
  • Zheng, D., Wang, Y., Cao, Q., Lee, V., Zheng, G., Sun, Y., Tan, T., Wang, Y., Alexander, S., Harris, D. (2011). Transfused Macrophages Ameliorate Pancreatic and Renal Injury in Murine Diabetes Mellitus. Nephron Experimental Nephrology, 118(4), e87-e99. [More Information]
  • Cooper, B., Branley, P., Bulfone, L., Collins, J., Craig, J., Fraenkel, M., Harris, A., Johnson, D., Kesselhut, J., Li, J., Tiller, D., Harris, D., Pollock, C., et al (2010). A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis. New England Journal of Medicine, 363(7), 609-619. [More Information]
  • Cooper, B., Harris, D., Pollock, C. (2010). Author's Reply: Early versus Late Initiation of Dialysis. New England Journal of Medicine, 15.14166667, 2368-2370.
  • Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, Y., Lee, V., Zheng, G., Tan, T., Ince, J., Alexander, S., Harris, D. (2010). IL-10/TGF-{beta}-Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis. Journal of the American Society of Nephrology, 21(6), 933-942. [More Information]
  • Tan, T., Zheng, G., Hsu, T., Wang, Y., Lee, V., Tian, X., Wang, Y., Cao, Q., Wang, Y., Harris, D. (2010). Macrophage Matrix Metalloproteinase-9 Mediates Epithelial-Mesenchymal Transition in Vitro in Murine Renal Tubular Cells. The American Journal of Pathology: cellular and molecular biology of disease, 176(3), 1256-1270. [More Information]
  • Phipps, L., Harris, D. (2010). Review: Modelling the dialysate. Nephrology, 15(4), 393-398. [More Information]
  • Vilayur, E., Gopinath, B., Harris, D., Burlutsky, G., McMahon, C., Mitchell, P. (2010). The Association Between Reduced GFR and Hearing Loss: A Cross-sectional Population-Based Study. American Journal of Kidney Diseases, 56(4), 661-669. [More Information]
  • Lee, V., Qin, X., Wang, Y., Zheng, G., Wang, Y., Wang, Y., Ince, J., Tan, T., Kairaitis, L., Alexander, S., Harris, D. (2010). The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis. Nephrology, Dialysis, Transplantation, 25(3), 717-730. [More Information]
  • Harris, D., Chen, Y., Saito, A., Yu, A. (2010). Timely Initiation of Dialysis for Chronic Kidney Disease: Perspective from Four Asian Countries. Nephrology, 15, 61-65. [More Information]
  • Watson, D., Zheng, G., Wu, H., Wang, Y., Wang, Y., Harris, D., Alexander, S. (2009). CCL2 DNA vaccine to treat renal disease. The International Journal of Biochemistry and Cell Biology, 41(4), 729-732. [More Information]
  • Prodjosudjadi, W., Suhardjbono, S., Suwitra, K., Pranawa, P., Raka Widiana, I., Loekman, J., Nainggolan, G., Prasanto, H., Wijayanti, Y., Harris, D. (2009). Detection and prevention of chronic kidney disease in Indonesia: Initial community screening. Nephrology, 14(7), 669-674. [More Information]
  • Zheng, G., Lyons, J., Tan, T., Wang, Y., Hsu, T., Min, D., Succar, L., Rangan, G., Hu, M., Henderson, B., Alexander, S., Harris, D. (2009). Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-{beta}1 in Renal Tubular Epithelial Cells. The American Journal of Pathology: cellular and molecular biology of disease, 175(2), 580-591. [More Information]
  • Vilayur, E., Harris, D. (2009). Emerging therapies for chronic kidney disease: what is their role? Nature Reviews. Neurology. [More Information]
  • Rangan, G., Wang, Y., Harris, D. (2009). NF-kappaB signalling in chronic kidney disease. Frontiers in Bioscience, 14, 3496-3522. [More Information]
  • Tong, A., Sainsbury, P., Chadban, S., Walker, R., Harris, D., Carter, S., Hall, B., Hawley, C., Craig, J. (2009). Patients' Experiences and Perspectives of Living With CKD. American Journal of Kidney Diseases, 53(4), 689-700. [More Information]
  • Tsukamoto, Y., Wang, H., Becker, G., Chen, H., Han, D., Harris, D., Imai, E., Jha, V., Li, P., Lee, E., et al (2009). Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries. Clinical and Experimental Nephrology, 13(3), 249-256. [More Information]
  • Wang, Y., Wang, Y., Cai, Q., Zheng, G., Lee, V., Zheng, D., Li, X., Tan, T., Harris, D. (2008). By Homing to the Kidney, Activated Macrophages Potently Exacerbate Renal Injury. The American Journal of Pathology: cellular and molecular biology of disease, 172(6), 1491-1499. [More Information]
  • Tong, A., Sainsbury, P., Carter, S., Hall, B., Harris, D., Walker, R., Hawley, C., Chadban, S., Craig, J. (2008). Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrology, Dialysis, Transplantation, 23(10), 3206-3214. [More Information]
  • Blyth, E., Favaloro, E., Harris, D., Kairaitis, L. (2008). Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis. Blood Coagulation and Fibrinolysis, 19(1), 23-25. [More Information]
  • Lee, V., Wang, Y., Wang, Y., Zheng, D., Polhill, T., Cao, Q., Wu, H., Alexander, I., Alexander, S., Harris, D. (2008). Regulatory immune cells in kidney disease. American Journal of Physiology: Renal Physiology (Print), 295(2), F335-F342. [More Information]
  • Wang, Y., Hu, M., Wang, Y., Polhill, T., Zhang, G., Wang, Y., Lee, V., Harris, D., Alexander, S. (2008). Regulatory T Cells in Renal Disease. International Journal of Clinical and Experimental Medicine, 1(4), 294-304. [More Information]
  • Stanley, M., Kelly, J., Harris, D. (2007). Acceptance onto dialysis. Australian Family Physician, 36(6), 1-1.
  • Zhimin, Z., Zimin, S., Qing, L., Aimei, Z., Huilan, L., Jingwei, X., Xiucai, X., Liangquan, G., Harris, D., Shilian, H., Wang, Y. (2007). Correlation of the CD4+CD25+ high T regulatory cells in recipients and their corresponding donors to acute GVHD. Transplant International, 20(5), 440-446. [More Information]
  • Disney, A., De Jersey, P., Kirkland, G., Mantha, M., Charlesworth, J., Gallagher, M., Harris, D., Gock, H., Mangos, G., MacMillan, J., et al (2007). Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian study. Nephrology, 12(1), 95-101. [More Information]
  • Wu, H., Wang, Y., Wang, Y., Hu, M., Zhang, G., Knight, J., Harris, D., Alexander, S. (2007). Depletion of γδ T Cells Exacerbates Murine Adriamycin Nephropathy. Journal of the American Society of Nephrology, 18(4), 1180-1189. [More Information]
  • Pollock, C., Cooper, B., Harris, D. (2007). Early Start Peritoneal Dialysis. Advances in Chronic Kidney Disease, 14(3), e27-e34. [More Information]
  • Wang, Y., Wang, Y., Zheng, G., Lee, V., Ouyang, L., Chang, D., Mahajan, D., Coombs, J., Wang, Y., Alexander, S., Harris, D. (2007). Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney International, 72(3), 290-299. [More Information]
  • Veness, M., Harris, D. (2007). Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Journal of Medical Imaging and Radiation Oncology, 51(10), 1-12. [More Information]
  • Li, X., Li, X., Qian, L., Wang, G., Zhang, H., Wang, X., Chen, K., Zhai, Z., Li, Q., Wang, Y., Harris, D. (2007). T Regulatory Cells Are Markedly Diminished in Diseased Salivary Glands of Patients with Primary Sjögren’s Syndrome. Journal of Rheumatology. [More Information]
  • Qin, X., Lee, V., Wang, Y., Zheng, G., Wang, Y., Alexander, S., Harris, D. (2006). A protective role for programmed death 1 in progression of murine adriamycin nephropathy. Kidney International, 70, 1244-1250. [More Information]
  • Lee, V., Wang, Y., Qin, X., Wang, Y., Zheng, G., Mahajan, D., Coombes, J., Rangan, G., Alexander, S., Harris, D. (2006). Adriamycin nephropathy in severe combined immunodeficient (SCID) mice. Nephrology, Dialysis, Transplantation. [More Information]
  • Mahajan, D., Wang, Y., Qin, X., Wang, Y., Zheng, G., Wang, Y., Alexander, S., Harris, D. (2006). CD4+CD25+ Regulatory T Cells Protect against Injury in an Innate Murine Model of Chronic Kidney Disease. Journal of the American Society of Nephrology, 17(10), 2731-2741. [More Information]
  • Zheng, G., Wang, Y., XIANG, S., Tay, Y., Wu, H., Watson, D., Coombes, J., Rangan, G., Alexander, S., Harris, D. (2006). DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury. Journal of the American Society of Nephrology, 17(2), 465-474. [More Information]
  • Wang, Y., Zhang, G., Wang, Y., Hu, M., Wu, H., Watson, D., Hori, S., Alexander, I., Harris, D., Alexander, S. (2006). Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. Journal of the American Society of Nephrology, 17(3), 697-706. [More Information]
  • Zheng, G., Zheng, L., Wang, Y., Wu, H., Kairaitis, L., Zhang, C., Tay, Y., Wang, Y., Alexander, S., Harris, D. (2006). NK cells do not mediate renal injury in murine adriamycin nephropathy. Kidney International, 69(7), 1159-1165. [More Information]
  • Harris, D., Thomas, M., Johnson, D., Nicholls, K., Gillin, A. (2006). Prevention of progression of kidney disease. Nephrology, 11(Suppl.1), S2-S197. [More Information]
  • Zhu, G., Wang, Y., Wang, J., Tay, Y., Yung, T., Rangan, G., Harris, D. (2006). Significance of CD25 positive cells and macrophages in noncrescentic IgA nephropathy. Renal Failure, 28(3), 229-235. [More Information]
  • Li, P., Weening, J., Dirks, J., Lui, S., Cheuk, E., Tang, S., Atkins, R., Mitch, W., Chow, K., D'Amico, G., Harris, D., et al (2005). A report with consensus statements of the International Society of Nephrology 2004 ConsensusWorkshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Kidney International, 67(Supplement 94), S2-S7. [More Information]
  • Kelly, J., Stanley, M., Harris, D. (2005). Acceptance onto Dialysis Guidelines. Nephrology, 94(s4), s46-s60.
  • Disney, A., De Jersey, P., Kirkland, G., Mantha, M., Charlesworth, J., Gallagher, M., Harris, D., Gock, H., Mangos, G., MacMillan, J., et al (2005). Aranesp (R) (darbepoetin alfa) administered once monthly (QM) maintains hemoglobin (Hb) levels in chronic kidney disease (CKD) patients. Nephrology, Dialysis, Transplantation, 20(Supplement 5), V254-V255.
  • Tay, Y., Wang, Y., Kairaitis, L., Rangan, G., Zhang, C., Harris, D. (2005). Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney International, 68(1), 391-398. [More Information]
  • Alfred, S., Coleman, P., Harris, D., Wigmore, T., Stachowski, E., Graudins, A. (2005). Delayed neurologic sequelae resulting from epidemic diethylene glycol poisoning. Journal of Toxicology. Clinical Toxicology, 43(3), 155-159. [More Information]
  • Rangan, G., Wang, Y., Tay, Y., Harris, D. (2005). Differential effects of albumin on cytokine gene expression in proximal tubular epithelial cells. Nephrology, Dialysis, Transplantation, 20(5), 1013-1014.
  • Rangan, G., Tay, Y., Harris, D. (2005). Differential effects of albumin on cytokine gene expression in proximal tubular epithelial cells. Nephrology, Dialysis, Transplantation, 20(5), 1013-4. [More Information]
  • Wu, H., Wang, Y., Tay, Y., Zheng, G., Zhang, C., Alexander, S., Harris, D. (2005). DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy. Kidney International, 67(6), 2178-2186. [More Information]
  • Rangan, G., Wang, Y., Harris, D., Tay, Y., Coombes, J. (2005). Effect of nephrotoxins on tubulointerstitial injury and NF-kappaB activation in Adriamycin nephropathy. Renal Failure, 27(5), 609-14. [More Information]
  • Lee, J., Simmons, A., Odell, R., Botto, S., Faramus, E., Schindhelm, K., Roeth, P., Nair, H., Harris, D. (2005). Hematologic and biochemical effects of the Gradiflow in an ex vivo ovine model. ASAIO Journal, 51(4), 366-371. [More Information]
  • Kairaitis, L., Wang, Y., Gassmann, M., Tay, Y., Harris, D. (2005). HIF-1α expression follows microvascular loss in advanced murine adriamycin nephrosis. American Journal of Physiology: Renal Physiology (Print), 288(1), F198-F206. [More Information]
  • Wang, Y., Mahajan, D., Tay, Y., Bao, B., Spicer, T., Kairaitis, L., Rangan, G., Harris, D. (2005). Partial depletion of macrophages by ED7 reduces renal injury in Adriamycin nephropathy. Nephrology, 10(5), 470-7. [More Information]
  • Harris, D., Rangan, G. (2005). Retardation of kidney failure -- applying principles to practice. Annals of the Academy of Medicine, Singapore (AAMS), 34(1), 16-23. [More Information]
  • Wavamunno, M., Harris, D. (2005). The need for early nephrology referral. Kidney International, 67(Supplement 94), S-128-S-132. [More Information]
  • Zhu, G., Li, R., Harris, D. (2005). The role of tubulointerstitial inflammation cells in Human IgA nephropathy. Chinese Journal of Nephrology, 21, 256-259.
  • Zheng, G., Wang, Y., Mahajan, D., Qin, X., Wang, Y., Wang, Y., Alexander, S., Harris, D. (2005). The role of tubulointerstitial inflammation. Kidney International, 67(S94), S96-S100. [More Information]
  • McMahon, L., Roger, S., Levin, A., Clarkson, A., Disney, A., Harris, D., Hawley, C., Healy, H., Kerr, P., Lynn, K., et al (2004). Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease. Journal of the American Society of Nephrology, 15(6), 1640-1647.
  • Harris, D. (2004). Editorial. Nephrology, 9(1), 1-1.
  • Roger, S., McMahon, L., Clarkson, A., Disney, A., Harris, D., Hawley, C., Healy, H., Kerr, P., Lynn, K., Parnham, A., et al (2004). Effects Of Early And Late Intervention With Epoetin Alpha On Left Ventricular Mass Among Patients With Chronic Kidney Disease (Stage 3 Or 4): Results Of A Randomized Clinical Trial. Journal of the American Society of Nephrology, 15(1), 148-56.
  • Zheng, G., Harris, D. (2004). Plasmin in renal interstitial fibrosis: Innocent or guilty? Kidney International, 66(1), 455-456.
  • Wang, Y., Tay, Y., Harris, D. (2004). Proximal Tubule Cells Stimulated By Lipopolysaccharide Inhibit Macrophage Activation. Kidney International, 66(2), 655-62.
  • Sadlier, D., Connolly, S., Kieran, N., Roxburgh, S., Brazil, D., Kairaitis, L., Wang, Y., Harris, D., Doran, P., Brady, H. (2004). Sequential Extracellular Matrix-Focused And Baited-Global Cluster Analysis Of Serial Transcriptomic Profiles Identifies Candidate Modulators Of Renal Tubulointerstitial Fibrosis In Murine Adriamycin-Induced Nephropathy. Journal of Biological Chemistry, 279(28), 29670-80.
  • Cooper, B., Branley, P., Bulfone, L., Collins, J., Craig, J., Dempster, J., Fraenkel, M., Harris, A., Harris, D., Johnson, D., Pollock, C., Tiller, D., et al (2004). The Initiating Dialysis Early And Late (Ideal) Study: Study Rationale And Design. Peritoneal Dialysis International, 24(2), 176-181.
  • Rangan, G., Harris, D. (2003). A blast from the mast? Kidney International, 64(3), 1134-1135.
  • Kairaitis, L., Wang, Y., Zheng, L., Tay, Y., Wang, Y., Harris, D. (2003). Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kidney International, 64(4), 1265-1272.
  • Johnson, D., AGAR, J., Collins, J., Disney, A., Harris, D., Ibels, L., Irish, A., SALTISSI, D., Suranyi, M. (2003). Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology, 8(1), 1-7.
  • Harris, D., Collins, J., Disney, A., Hawley, C., Irish, A., Kerr, P., Makris, A., Lynn, K., Pollock, C., Roger, S., et al (2002). Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia. Nephrology, 7(6), S173-S180.
  • Wang, Y., Harris, D., Rangan, G. (2002). Dietary Quercetin Augments activator Protein-1 and Does Not Reduce Nuclear Factor-KB in the Renal Cortex of Rats with Established Chronic Glomerular Disease. Nephron Journals, 90(3), 313-319.
  • Thomas, M., Harris, D. (2002). Management of bacterial peritonitis and exit-site infections in continuous ambulatory peritoneal dialysis. Nephrology, 7(6), 267-271.
  • Thomas, M., Harris, D. (2002). Problems and advantages of continuous renal replacement therapy. Nephrology, 7(3), 110-114.
  • Thomas, M., Harris, D. (2002). Renal effects of cyclo-oxygenase-2 inhibition. Nephrology, 7(6), 281-286.
  • Wang, Y., Yi, S., Tay, Y., Feng, X., Kairaitis, L., Harris, D. (2002). Transfection of tubule cells with Fas ligand causes leukocyte apoptosis. Kidney International, 61(4), 1303-1311.

Conferences

  • Wang, Y., Zhang, G., Wang, Y., Hu, M., Wu, H., Watson, D., Harris, D., Alexander, S. (2006). T cell vaccination protects against active Heymann nephritis: A CD8 T cell mechanism. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.

Other

  • Harris, D. (2012), Training Nephrologists From Developing Countries: does it have a positive impact? (Commentary on Hemodialysis.com).

2014

  • Zheng, D., Wen, L., Li, C., Peng, A., Cao, Q., Wang, Y., Harris, D. (2014). Adoptive transfer of bone marrow dendritic cells failed to localize in the renal cortex and to improve renal injury in adriamycin nephropathy. Nephron Experimental Nephrology, 126(1), 8-15. [More Information]
  • Harris, D., Feehally, J. (2014). Age, CKD and other kidney messages. Medical Journal of Australia, 200(4), 191-192. [More Information]
  • Wong, M., Pollock, C., Cooper, B., Branley, P., Collins, J., Craig, J., Kesselhut, J., Luxton, G., Pilmore, A., Harris, D., et al (2014). Association between GFR estimated by multiple methods at dialysis commencement and patient survival. Clinical journal of the American Society of Nephrology, 9(1), 135-142. [More Information]
  • Bose, B., Badve, S., Hiremath, S., Boudville, N., Brown, F., Cass, A., de Zoysa, J., Fassett, R., Faull, R., Harris, D., Perkovic, V., Rangan, G., et al (2014). Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation, 29(2), 406-413. [More Information]
  • Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, C., Wang, X., Lee, V., Wang, Y., Wang, Y., Zheng, G., Tan, T., Harris, D., et al (2014). Failed renoprotection by alternatively activated macrophages from bone marrow due to proliferation-dependent phenotype switch in vivo. Kidney International, 85(4), 794-806. [More Information]
  • Feehally, J., Couser, W., Dupuis, S., Finkelstein, F., Harden, P., Harris, D., Lameire, N., Naicker, S., Remuzzi, G., Segantini, L., et al (2014). Nephrology in developing countries: the ISN's story. The Lancet, 383(9925), 1271-1272. [More Information]
  • Wang, Y., Wang, Y., Wang, Y., Zheng, G., Tan, T., Lee, S., Zhang, J., Zhang, G., Hu, M., Wang, C., Cao, Q., Zhao, Y., Harris, D., et al (2014). Regulatory T cells require renal antigen recognition through the TCR to protect against injury in nephritis. International Journal of Clinical and Experimental Pathology, 7(1), 38-47.

2013

  • Gopinath, B., Harris, D., Flood, V., Burlutsky, G., Mitchell, P. (2013). A better diet quality is associated with a reduced likelihood of CKD in older adults. Nutrition Metabolism and Cardiovascular Diseases, 23(10), 937-943. [More Information]
  • Zhou, J., Wang, Y., Harris, D., Medbury, H., Williams, H., Durkan, A., Alexander, S., Lee, V., Tan, T., Hu, M., et al (2013). Adenine-induced Chronic Kidney Disease Is Associated with Arterial Macrophage Infiltration and Medial Vascular Calcification. Nephrology, 18(Supp 1), 52-52.
  • Wang, Y., Sawyer, A., Zhou, J., Zhang, G., Wang, Y., Hu, M., Roberts, V., Dwyer, K., Harris, D., Alexander, S. (2013). Analysis of Linkage of P2x7r to Balb/C Associated Kidney Injury in the Adriamycin Murine Model in F2 Mice. Nephrology, 18(Supp. 1), 60-60.
  • Tian, X., Zhang, J., Tan, T., Lyons, G., Zhao, H., Niu, B., Lee, S., Tsatralis, T., Zhao, Y., Wang, Y., Cao, Q., Wang, C., Wang, Y., Lee, V., Zheng, G., Harris, D., et al (2013). Association of beta catenin with P-Smad3 but not LEF-1 dissociates in vitro profibrotic from anti-inflammatory effects of TGF- beta1. Journal of Cell Science, 126(1), 67-76. [More Information]
  • Tian, X., Dong, Y., Zhang, J., Wang, H., Xie, J., Niu, B., Harris, D., Zheng, G. (2013). Beta-Catenin and Kidney Fibrosis. In Abel Braunfeld, Gabriel R. Mirsky (Eds.), Beta-Catenin: Structure, Function and Clinical Significance, (pp. 63-88). New York: Nova Science Publishers.
  • Wang, C., Yu, X., Cao, Q., Wang, Y., Zheng, G., Tan, T., Zhao, H., Zhao, Y., Wang, Y., Harris, D. (2013). Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunology, 14(1), 1-10. [More Information]
  • Rangan, G., Schwensen, K., Foster, S., Korgaonkar, M., Peduto, A., Harris, D. (2013). Chronic effects of dietary Vitamin D deficiency without increased calcium supplementation on the progression of experimental polycystic kidney disease. American Journal of Physiology: Renal Physiology (Print), 305(4), F574-F582. [More Information]
  • Zhou, J., Wang, Y., Lee, V., Zhang, G., Medbury, H., Williams, H., Wang, Y., Harris, D., Alexander, S., Durkan, A. (2013). Cx3cr1-dec205 dc-targeted dna Vaccine Induces Specific Antibodies and Limits Atherosclerosis and Macrophage Infiltration in the apo-e Knockout Mouse Model of Atherosclerosis. Nephrology, 18(Supp. 1), 16-16.
  • Wang, Y., Zhou, J., Wang, Y., Watson, D., Zhang, G., Hu, M., Wu, H., Zheng, G., Wang, Y., Durkan, A., Harris, D., Alexander, S. (2013). Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease. International Journal of Clinical and Experimental Pathology, 6(3), 326-333. [More Information]
  • Rosansky, S., Cancarini, G., Clark, W., Eggers, P., Germaine, M., Glassock, R., Goldfarb, D., Harris, D., Hwang, S., Imperial, E., et al (2013). Dialysis Initiation: What's the Rush? Seminars in Dialysis, 26(6), 650-657. [More Information]
  • Medbury, H., James, V., Ngo, J., Hitos, K., Wang, Y., Harris, D., Fletcher, J. (2013). Differing association of macrophage subsets with atherosclerotic plaque stability. International Angiology, 32(1), 74-84. [More Information]
  • Lu, J., Cao, Q., Zheng, D., Sun, Y., Wang, C., Yu, X., Wang, Y., Lee, V., Zheng, G., Tan, T., Wang, X., Harris, D., Wang, Y., et al (2013). Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease. Kidney International, 84(4), 745-755. [More Information]
  • Wang, Y., Wang, Y., Wang, Y., Zheng, G., Zhang, G., Zhou, J., Tan, T., Cao, Q., Hu, M., Watson, D., Wu, H., Zheng, D., Wang, C., Harris, D., et al (2013). DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats. Kidney International, 83(2), 223-232. [More Information]
  • Whalley, G., Marwick, T., Doughty, R., Cooper, B., Johnson, D., Pilmore, A., Harris, D., Pollock, C., Collins, J. (2013). Effect of Early Initiation of Dialysis on Cardiac Structure and Function: Results From the Echo Substudy of the IDEAL Trial. American Journal of Kidney Diseases, 61(2), 262-270. [More Information]
  • Cao, Q., Wang, X., Wang, C., Lee, V., Ye, Q., Zheng, G., Zhao, Y., Alexander, S., Wang, Y., Harris, D. (2013). Kidney Cd103+ Dcs Exacerbate Renal Injury Through Activating Cd8+ T Cells in Adriamycin Nephropathy. Nephrology, 18(Supp. 1), 24-24.
  • Tan, T., Zheng, G., Hsu, T., Lee, S., Zhang, J., Zhao, Y., Tian, X., Wang, Y., Wang, Y., Cao, Q., Wang, Y., Lee, V., Wang, C., Zheng, D., Alexander, S., Harris, D., et al (2013). Matrix metalloproteinase-9 of tubular and macrophage origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin cleavage. Laboratory Investigation, 93(4), 434-449. [More Information]
  • Zhao, H., Dong, Y., Tian, X., Tan, T., Liu, Z., Zhao, Y., Zhang, Y., Harris, D., Zheng, G. (2013). Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases. World Journal of Nephrology, 2(3), 84-89. [More Information]
  • Wang, Y., Wang, C., Cao, Q., Ye, Q., Zheng, G., Alexander, S., Jones, D., Harris, D. (2013). Midkine Antibodies Prevent Renal Injury in Adriamycin Nephropathy. Nephrology, 18(Supp. 1), 59-59.
  • Zhao, Y., Zhao, H., Zhang, Y., Zhang, J., Tsatralis, T., Cao, Q., Wang, Y., Wang, Y., Zheng, G., Harris, D. (2013). Notch Signaling Mediates Mmp-9-Dependent Endothelialmesenchymal Transition Downstream of Tgf-B in Human Renal Glomerular Endothelial Cells. Nephrology, 18(Supp. 1), 52-52.
  • Cao, Q., Wang, Y., Harris, D. (2013). Pathogenic and protective role of macrophages in kidney disease. American Journal of Physiology: Renal Physiology (Print), 305(1), F3-F11. [More Information]
  • Ta, M., Rao, P., Korgaonkar, M., Foster, S., Peduto, A., Harris, D., Rangan, G. (2013). Pyrrolidine Dithiocarbamate Attenuates Kidney Enlargement in Experimental Polycystic Kidney Disease. Nephrology, 18(Supp. 1), 37-37.
  • Rangan, G., Harris, D. (2013). Rationale and Design of an Observational Study to Determine the Effects of Cholecalciferol on Hypertension, Proteinuria and Urinary MCP-1 in ADPKD. Current Hypertension Reviews, 9(2), 115-120. [More Information]
  • Gopinath, B., Harris, D., Wall, J., Kifley, A., Mitchell, P. (2013). Relationship between thyroid dysfunction and chronic kidney disease in community-dwelling older adults. Maturitas, 75(2), 159-164. [More Information]
  • Forbes, J., Harris, D., Cooper, M. (2013). Report on ISN Forefronts, Melbourne, Australia, 4-7 October 2012: tubulointerstitial disease in diabetic nephropathy. Kidney International, 84(4), 653-656. [More Information]
  • Ta, M., Harris, D., Rangan, G. (2013). Role of interstitial inflammation in the pathogenesis of polycystic kidney disease. Nephrology, 18(5), 317-330. [More Information]
  • Wong, M., Pollock, C., Cooper, B., Branley, P., Collins, J., Craig, J., Pilmore, A., Kesselhut, J., Harris, D., Johnson, D. (2013). The Association Between Glomerular Filtration Rate Estimated by Multiple Methods at Dialysis Commencement and Patient Survival in the Ideal Trial. Nephrology, 18(Supp. 1), 17-17.
  • Zhang, G., Zhang, J., Zhang, H., Tsatralis, T., Hu, M., Wang, Y., Cao, Q., Wang, Y., Zheng, G., Harris, D. (2013). The Role of B-Catenin in TGF-B1-Induced Foxp3 Expression and Treg Induction. Nephrology, 18(Supp. 1), 59-59.
  • Lee, V., Wang, Y., Harris, D. (2013). The Role of the Immune System in the Pathogenesis of Hypertension. Current Hypertension Reviews, 9(1), 76-84. [More Information]
  • Gopinath, B., Harris, D., Burlutsky, G., Mitchell, P. (2013). Use of Community Support Services and Activity Limitations Among Older Adults With Chronic Kidney Disease. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 68(6), 741-747. [More Information]

2012

  • Wang, Y., Zhang, G., Hu, M., Polhill, T., Sawyer, A., Zhou, J., Saito, M., Watson, D., Wu, H., Wang, Y., Wang, X., Wang, Y., Harris, D., Alexander, S. (2012). CD8+ Regulatory T Cells Induced by T Cell Vaccination Protect Against Autoimmune Nephritis. Journal of the American Society of Nephrology, 23(6), 1058-1067. [More Information]
  • Zhou, J., Wang, Y., Lee, V., Phoon, R., Zhang, G., Wang, Y., Tan, T., Hu, M., Wang, D., Saito, M., Harris, D., Durkan, A., et al (2012). DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration. International Journal of Clinical and Experimental Medicine, 5(1), 24-33. [More Information]
  • Johnson, D., Wong, M., Cooper, B., Branley, P., Bulfone, L., Collins, J., Craig, J., Fraenkel, M., Harris, A., Kesselhut, J., Tiller, D., Harris, D., Pollock, C., et al (2012). Effect of timing of dialysis commencement on clinical outcomes of patients with planned initiation of peritoneal dialysis in the ideal trial. Peritoneal Dialysis International, 32(6), 595-604. [More Information]
  • Polhill, T., Zhang, G., Hu, M., Sawyer, A., Zhou, J., Saito, M., Webster, K., Wang, Y., Wang, Y., Grey, S., Harris, D., Alexander, S., Wang, Y., et al (2012). IL-2/IL-2Ab Complexes Induce Regulatory T Cell Expansion and Protect against Proteinuric CKD. Journal of the American Society of Nephrology, 23(8), 1303-1308. [More Information]
  • Zheng, D., Cao, Q., Lee, V., Wang, Y., Zheng, G., Wang, Y., Tan, T., Wang, C., Alexander, S., Harris, D., Wang, Y. (2012). Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease. Kidney International, 81(9), 892-902. [More Information]
  • Zheng, G., Zhang, J., Tan, T., Hsu, T., Tian, X., Niu, B., Harris, D. (2012). Matrix Metalloproteinases (MMPs) in Renal Fibrosis. In Namae Oshiro and Eiko Miyagi (Eds.), Matrix Metalloproteinases: Biology, Functions and Clinical Implications, (pp. 169-186). New York: Nova Science Publishers, Inc.
  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2012). Pocket Guide to Clinical Dialysis. Sydney, Australia: McGraw Hill.
  • Wang, Y., McRae, J., Robson, S., Cowan, P., Zhang, G., Hu, M., Polhill, T., Wang, Y., Zheng, G., Wang, Y., Lee, V., Harris, D., Alexander, S., et al (2012). Regulatory T cells participate in CD39-mediated protection from renal injury. European Journal of Immunology, 42(9), 2441-2451. [More Information]
  • Becker, G., Collins, J., Harris, D. (2012). Renal Disease in the Oceania Region. In M Taal, G Chertow, P Marsden, K Skorecki, A Yu and B Brenner (Eds.), Brenner & Rector's The Kidney, (pp. 2803-2821). Philadelphia: Saunders Elsevier.
  • Myint, T., Cooper, B., Pollock, C., Harris, D. (2012). Starting Dialysis Early: No Survival, Quality of Life, or Cost Advantages. Seminars in Dialysis, 25(5), 522-523. [More Information]
  • Harris, D., Dupuis, S., Couser, W., Feehally, J. (2012). Training nephrologists from developing countries: does it have a positive impact? Kidney International Supplements, 2, 275-278. [More Information]
  • Harris, D. (2012), Training Nephrologists From Developing Countries: does it have a positive impact? (Commentary on Hemodialysis.com).
  • Pollock, C., Cooper, B., Harris, D. (2012). When should we commence dialysis? The story of a lingering problem and today's scene after the IDEAL study. Nephrology, Dialysis, Transplantation, 27(6), 2162-2166. [More Information]

2011

  • Harris, D. (2011). A new admiral for the flagship. Kidney International, 80(9), 899-899. [More Information]
  • Lee, V., Harris, D. (2011). Adriamycin nephropathy: A model of focal segmental glomerulosclerosis. Nephrology, 16(1), 30-38. [More Information]
  • Li, P., Chow, K., Matsuo, S., Yang, C., Jha, V., Becker, G., Chen, N., Sharma, S., Chittinandana, A., Chowdhury, S., Harris, D., et al (2011). Asian chronic kidney disease best practice recommendations: Positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology, 16(7), 633-641. [More Information]
  • Gopinath, B., Harris, D., Flood, V., Burlutsky, G., Brand-Miller, J., Mitchell, P. (2011). Carbohydrate Nutrition Is Associated with the 5-Year Incidence of Chronic Kidney Disease 1–3. The Journal of Nutrition, 141(3), 433-439. [More Information]
  • Gopinath, B., Harris, D., Flood, V., Burlutsky, G., Mitchell, P. (2011). Consumption of long-chain n-3 PUFA, α-linolenic acid and fish is associated with the prevalence of chronic kidney disease. British Journal of Nutrition, 105(9), 1361-1368. [More Information]
  • Harris, A., Cooper, B., Li, J., Bulfone, L., Branley, P., Collins, J., Craig, J., Fraenkel, M., Johnson, D., Kesselhut, J., Tiller, D., Pollock, C., Harris, D., et al (2011). Cost-effectiveness of initiating dialysis early: A randomized controlled trial. American Journal of Kidney Diseases, 57(5), 707-715. [More Information]
  • Tian, X., Liu, Z., Niu, B., Zhang, J., Tan, T., Lee, S., Zhao, Y., Harris, D., Zheng, G. (2011). E-cadherin/β-catenin complex and the epithelial barrier. Journal of Biomedicine and Biotechnology, 2011, 567305-1-567305-6. [More Information]
  • Schwensen, K., Burgess, J., Graf, N., Alexander, S., Harris, D., Phillips, J., Rangan, G. (2011). Early Cyst Growth Is Associated with the Increased Nuclear Expression of Cyclin D1/Rb Protein in an Autosomal-Recessive Polycystic Kidney Disease Rat Model. Nephron Experimental Nephrology, 117(4), e93-e103. [More Information]
  • Cao, Q., Wang, C., Zheng, D., Wang, Y., Lee, V., Wang, Y., Zheng, G., Tan, T., Yu, D., Alexander, S., Harris, D., Wang, Y. (2011). IL-25 Induces M2 Macrophages and Reduces Renal Injury in Proteinuric Kidney Disease. Journal of the American Society of Nephrology, 22(7), 1229-1239. [More Information]
  • Harris, A., Pollock, C., Harris, D. (2011). In Reply to ‘Regarding Early Initiation of Dialysis’. American Journal of Kidney Diseases, 58(3), 492-492. [More Information]
  • Harris, D., Gopinath, B., Mitchell, P. (2011). Is the link between chronic kidney disease and hearing loss in older patients likely to be causal? Aging Health, 7(1), 5-7.
  • Cao, Q., Zheng, D., Wang, Y., Harris, D. (2011). Macrophages and Dendritic Cells for Treating Kidney Disease. Nephron Experimental Nephrology, 117(3), e47-e52. [More Information]
  • Wang, Y., Harris, D. (2011). Macrophages in renal disease. Journal of the American Society of Nephrology, 22(1), 21-27. [More Information]
  • Collins, J., Cooper, B., Branley, P., Bulfone, L., Craig, J., Fraenkel, M., Harris, A., Johnson, D., Kesselhut, J., Li, J., Tiller, D., Pollock, C., et al (2011). Outcomes of patients with planned initiation of hemodialysis in the IDEAL Trial. In Ronco C; Rosner M (Eds.), Contributions to Nephrology: Hemodialysis New Methods and Future Technology, (pp. 1-9). Basel, Switzerland: S. Karger AG.
  • Lee, V., Cao, Q., Wang, Y., Harris, D. (2011). Role of Macrophages in Renal Injury,Repair and Regeneration. In Michael S. Goligorsky (Eds.), Regenerative Nephrology, (pp. 125-139). USA: Elsevier.
  • Succar, L., Harris, D., Rangan, G. (2011). Role of the Mammalian Target of Rapamycin (mTOR) Signalling Pathway in Podocytes in Glomerular Disease. In Sharma S. Prabhakar (Eds.), An Update on Glomerulopathies – Etiology and Pathogenesis, (pp. 183-202). Rijeka, Croatia: InTech Publishers.
  • Sun, Y., Yu, H., Zheng, D., Cao, Q., Wang, Y., Harris, D., Wang, Y. (2011). Sudan Black B Reduces Autofluorescence in Murine Renal Tissue. Archives of Pathology and Laboratory Medicine, 135(10), 1335-1342. [More Information]
  • Zheng, D., Wang, Y., Cao, Q., Lee, V., Zheng, G., Sun, Y., Tan, T., Wang, Y., Alexander, S., Harris, D. (2011). Transfused Macrophages Ameliorate Pancreatic and Renal Injury in Murine Diabetes Mellitus. Nephron Experimental Nephrology, 118(4), e87-e99. [More Information]

2010

  • Cooper, B., Branley, P., Bulfone, L., Collins, J., Craig, J., Fraenkel, M., Harris, A., Johnson, D., Kesselhut, J., Li, J., Tiller, D., Harris, D., Pollock, C., et al (2010). A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis. New England Journal of Medicine, 363(7), 609-619. [More Information]
  • Cooper, B., Harris, D., Pollock, C. (2010). Author's Reply: Early versus Late Initiation of Dialysis. New England Journal of Medicine, 15.14166667, 2368-2370.
  • Cao, Q., Wang, Y., Zheng, D., Sun, Y., Wang, Y., Lee, V., Zheng, G., Tan, T., Ince, J., Alexander, S., Harris, D. (2010). IL-10/TGF-{beta}-Modified Macrophages Induce Regulatory T Cells and Protect against Adriamycin Nephrosis. Journal of the American Society of Nephrology, 21(6), 933-942. [More Information]
  • Tan, T., Zheng, G., Hsu, T., Wang, Y., Lee, V., Tian, X., Wang, Y., Cao, Q., Wang, Y., Harris, D. (2010). Macrophage Matrix Metalloproteinase-9 Mediates Epithelial-Mesenchymal Transition in Vitro in Murine Renal Tubular Cells. The American Journal of Pathology: cellular and molecular biology of disease, 176(3), 1256-1270. [More Information]
  • Phipps, L., Harris, D. (2010). Review: Modelling the dialysate. Nephrology, 15(4), 393-398. [More Information]
  • Vilayur, E., Gopinath, B., Harris, D., Burlutsky, G., McMahon, C., Mitchell, P. (2010). The Association Between Reduced GFR and Hearing Loss: A Cross-sectional Population-Based Study. American Journal of Kidney Diseases, 56(4), 661-669. [More Information]
  • Lee, V., Qin, X., Wang, Y., Zheng, G., Wang, Y., Wang, Y., Ince, J., Tan, T., Kairaitis, L., Alexander, S., Harris, D. (2010). The CD40-CD154 co-stimulation pathway mediates innate immune injury in adriamycin nephrosis. Nephrology, Dialysis, Transplantation, 25(3), 717-730. [More Information]
  • Harris, D., Chen, Y., Saito, A., Yu, A. (2010). Timely Initiation of Dialysis for Chronic Kidney Disease: Perspective from Four Asian Countries. Nephrology, 15, 61-65. [More Information]

2009

  • Watson, D., Zheng, G., Wu, H., Wang, Y., Wang, Y., Harris, D., Alexander, S. (2009). CCL2 DNA vaccine to treat renal disease. The International Journal of Biochemistry and Cell Biology, 41(4), 729-732. [More Information]
  • Prodjosudjadi, W., Suhardjbono, S., Suwitra, K., Pranawa, P., Raka Widiana, I., Loekman, J., Nainggolan, G., Prasanto, H., Wijayanti, Y., Harris, D. (2009). Detection and prevention of chronic kidney disease in Indonesia: Initial community screening. Nephrology, 14(7), 669-674. [More Information]
  • Zheng, G., Lyons, J., Tan, T., Wang, Y., Hsu, T., Min, D., Succar, L., Rangan, G., Hu, M., Henderson, B., Alexander, S., Harris, D. (2009). Disruption of E-Cadherin by Matrix Metalloproteinase Directly Mediates Epithelial-Mesenchymal Transition Downstream of Transforming Growth Factor-{beta}1 in Renal Tubular Epithelial Cells. The American Journal of Pathology: cellular and molecular biology of disease, 175(2), 580-591. [More Information]
  • Vilayur, E., Harris, D. (2009). Emerging therapies for chronic kidney disease: what is their role? Nature Reviews. Neurology. [More Information]
  • Rangan, G., Wang, Y., Harris, D. (2009). NF-kappaB signalling in chronic kidney disease. Frontiers in Bioscience, 14, 3496-3522. [More Information]
  • Tong, A., Sainsbury, P., Chadban, S., Walker, R., Harris, D., Carter, S., Hall, B., Hawley, C., Craig, J. (2009). Patients' Experiences and Perspectives of Living With CKD. American Journal of Kidney Diseases, 53(4), 689-700. [More Information]
  • Tsukamoto, Y., Wang, H., Becker, G., Chen, H., Han, D., Harris, D., Imai, E., Jha, V., Li, P., Lee, E., et al (2009). Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries. Clinical and Experimental Nephrology, 13(3), 249-256. [More Information]

2008

  • Wang, Y., Wang, Y., Cai, Q., Zheng, G., Lee, V., Zheng, D., Li, X., Tan, T., Harris, D. (2008). By Homing to the Kidney, Activated Macrophages Potently Exacerbate Renal Injury. The American Journal of Pathology: cellular and molecular biology of disease, 172(6), 1491-1499. [More Information]
  • Harris, D. (2008). Clinical Cases in Kidney Disease. Australia: McGraw Hill.
  • Tong, A., Sainsbury, P., Carter, S., Hall, B., Harris, D., Walker, R., Hawley, C., Chadban, S., Craig, J. (2008). Patients' priorities for health research: focus group study of patients with chronic kidney disease. Nephrology, Dialysis, Transplantation, 23(10), 3206-3214. [More Information]
  • Blyth, E., Favaloro, E., Harris, D., Kairaitis, L. (2008). Protein Z is reduced in chronic kidney disease and not elevated in patients on haemodialysis. Blood Coagulation and Fibrinolysis, 19(1), 23-25. [More Information]
  • Lee, V., Wang, Y., Wang, Y., Zheng, D., Polhill, T., Cao, Q., Wu, H., Alexander, I., Alexander, S., Harris, D. (2008). Regulatory immune cells in kidney disease. American Journal of Physiology: Renal Physiology (Print), 295(2), F335-F342. [More Information]
  • Wang, Y., Hu, M., Wang, Y., Polhill, T., Zhang, G., Wang, Y., Lee, V., Harris, D., Alexander, S. (2008). Regulatory T Cells in Renal Disease. International Journal of Clinical and Experimental Medicine, 1(4), 294-304. [More Information]

2007

  • Stanley, M., Kelly, J., Harris, D. (2007). Acceptance onto dialysis. Australian Family Physician, 36(6), 1-1.
  • Lee, V., Harris, D., Anderson, R., Schrier, R. (2007). Acute Renal Failure. In Robert W. Schrier (Eds.), Diseases of the Kidney and Urinary Tract, (pp. 986-1034). Philadelphia: Lippincott Williams & Wilkins.
  • Harris, D. (2007). Clinical Cases in Kidney Disease. Australia: McGraw Hill.
  • Zhimin, Z., Zimin, S., Qing, L., Aimei, Z., Huilan, L., Jingwei, X., Xiucai, X., Liangquan, G., Harris, D., Shilian, H., Wang, Y. (2007). Correlation of the CD4+CD25+ high T regulatory cells in recipients and their corresponding donors to acute GVHD. Transplant International, 20(5), 440-446. [More Information]
  • Disney, A., De Jersey, P., Kirkland, G., Mantha, M., Charlesworth, J., Gallagher, M., Harris, D., Gock, H., Mangos, G., MacMillan, J., et al (2007). Darbepoetin alfa administered monthly maintains haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis: a multicentre, open-label, Australian study. Nephrology, 12(1), 95-101. [More Information]
  • Wu, H., Wang, Y., Wang, Y., Hu, M., Zhang, G., Knight, J., Harris, D., Alexander, S. (2007). Depletion of γδ T Cells Exacerbates Murine Adriamycin Nephropathy. Journal of the American Society of Nephrology, 18(4), 1180-1189. [More Information]
  • Pollock, C., Cooper, B., Harris, D. (2007). Early Start Peritoneal Dialysis. Advances in Chronic Kidney Disease, 14(3), e27-e34. [More Information]
  • Wang, Y., Wang, Y., Zheng, G., Lee, V., Ouyang, L., Chang, D., Mahajan, D., Coombs, J., Wang, Y., Alexander, S., Harris, D. (2007). Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney International, 72(3), 290-299. [More Information]
  • Veness, M., Harris, D. (2007). Role of radiotherapy in the management of organ transplant recipients diagnosed with non-melanoma skin cancers. Journal of Medical Imaging and Radiation Oncology, 51(10), 1-12. [More Information]
  • Li, X., Li, X., Qian, L., Wang, G., Zhang, H., Wang, X., Chen, K., Zhai, Z., Li, Q., Wang, Y., Harris, D. (2007). T Regulatory Cells Are Markedly Diminished in Diseased Salivary Glands of Patients with Primary Sjögren’s Syndrome. Journal of Rheumatology. [More Information]

2006

  • Qin, X., Lee, V., Wang, Y., Zheng, G., Wang, Y., Alexander, S., Harris, D. (2006). A protective role for programmed death 1 in progression of murine adriamycin nephropathy. Kidney International, 70, 1244-1250. [More Information]
  • Lee, V., Wang, Y., Qin, X., Wang, Y., Zheng, G., Mahajan, D., Coombes, J., Rangan, G., Alexander, S., Harris, D. (2006). Adriamycin nephropathy in severe combined immunodeficient (SCID) mice. Nephrology, Dialysis, Transplantation. [More Information]
  • Mahajan, D., Wang, Y., Qin, X., Wang, Y., Zheng, G., Wang, Y., Alexander, S., Harris, D. (2006). CD4+CD25+ Regulatory T Cells Protect against Injury in an Innate Murine Model of Chronic Kidney Disease. Journal of the American Society of Nephrology, 17(10), 2731-2741. [More Information]
  • Zheng, G., Wang, Y., XIANG, S., Tay, Y., Wu, H., Watson, D., Coombes, J., Rangan, G., Alexander, S., Harris, D. (2006). DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury. Journal of the American Society of Nephrology, 17(2), 465-474. [More Information]
  • Wang, Y., Zhang, G., Wang, Y., Hu, M., Wu, H., Watson, D., Hori, S., Alexander, I., Harris, D., Alexander, S. (2006). Foxp3-transduced polyclonal regulatory T cells protect against chronic renal injury from adriamycin. Journal of the American Society of Nephrology, 17(3), 697-706. [More Information]
  • Zheng, G., Zheng, L., Wang, Y., Wu, H., Kairaitis, L., Zhang, C., Tay, Y., Wang, Y., Alexander, S., Harris, D. (2006). NK cells do not mediate renal injury in murine adriamycin nephropathy. Kidney International, 69(7), 1159-1165. [More Information]
  • Harris, D., Thomas, M., Johnson, D., Nicholls, K., Gillin, A. (2006). Prevention of progression of kidney disease. Nephrology, 11(Suppl.1), S2-S197. [More Information]
  • Zhu, G., Wang, Y., Wang, J., Tay, Y., Yung, T., Rangan, G., Harris, D. (2006). Significance of CD25 positive cells and macrophages in noncrescentic IgA nephropathy. Renal Failure, 28(3), 229-235. [More Information]
  • Wang, Y., Zhang, G., Wang, Y., Hu, M., Wu, H., Watson, D., Harris, D., Alexander, S. (2006). T cell vaccination protects against active Heymann nephritis: A CD8 T cell mechanism. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand (2006), Australia: Nature Publishing Group.

2005

  • Li, P., Weening, J., Dirks, J., Lui, S., Cheuk, E., Tang, S., Atkins, R., Mitch, W., Chow, K., D'Amico, G., Harris, D., et al (2005). A report with consensus statements of the International Society of Nephrology 2004 ConsensusWorkshop on Prevention of Progression of Renal Disease, Hong Kong, June 29, 2004. Kidney International, 67(Supplement 94), S2-S7. [More Information]
  • Kelly, J., Stanley, M., Harris, D. (2005). Acceptance onto Dialysis Guidelines. Nephrology, 94(s4), s46-s60.
  • Disney, A., De Jersey, P., Kirkland, G., Mantha, M., Charlesworth, J., Gallagher, M., Harris, D., Gock, H., Mangos, G., MacMillan, J., et al (2005). Aranesp (R) (darbepoetin alfa) administered once monthly (QM) maintains hemoglobin (Hb) levels in chronic kidney disease (CKD) patients. Nephrology, Dialysis, Transplantation, 20(Supplement 5), V254-V255.
  • Harris, D., Elder, G., Kairaitis, L., Rangan, G. (2005). Basic Clinical Dialysis. Sydney: McGraw-Hill, Medical Pub. Division.
  • Tay, Y., Wang, Y., Kairaitis, L., Rangan, G., Zhang, C., Harris, D. (2005). Can murine diabetic nephropathy be separated from superimposed acute renal failure? Kidney International, 68(1), 391-398. [More Information]
  • Alfred, S., Coleman, P., Harris, D., Wigmore, T., Stachowski, E., Graudins, A. (2005). Delayed neurologic sequelae resulting from epidemic diethylene glycol poisoning. Journal of Toxicology. Clinical Toxicology, 43(3), 155-159. [More Information]
  • Rangan, G., Wang, Y., Tay, Y., Harris, D. (2005). Differential effects of albumin on cytokine gene expression in proximal tubular epithelial cells. Nephrology, Dialysis, Transplantation, 20(5), 1013-1014.
  • Rangan, G., Tay, Y., Harris, D. (2005). Differential effects of albumin on cytokine gene expression in proximal tubular epithelial cells. Nephrology, Dialysis, Transplantation, 20(5), 1013-4. [More Information]
  • Wu, H., Wang, Y., Tay, Y., Zheng, G., Zhang, C., Alexander, S., Harris, D. (2005). DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy. Kidney International, 67(6), 2178-2186. [More Information]
  • Rangan, G., Wang, Y., Harris, D., Tay, Y., Coombes, J. (2005). Effect of nephrotoxins on tubulointerstitial injury and NF-kappaB activation in Adriamycin nephropathy. Renal Failure, 27(5), 609-14. [More Information]
  • Lee, J., Simmons, A., Odell, R., Botto, S., Faramus, E., Schindhelm, K., Roeth, P., Nair, H., Harris, D. (2005). Hematologic and biochemical effects of the Gradiflow in an ex vivo ovine model. ASAIO Journal, 51(4), 366-371. [More Information]
  • Kairaitis, L., Wang, Y., Gassmann, M., Tay, Y., Harris, D. (2005). HIF-1α expression follows microvascular loss in advanced murine adriamycin nephrosis. American Journal of Physiology: Renal Physiology (Print), 288(1), F198-F206. [More Information]
  • Wang, Y., Mahajan, D., Tay, Y., Bao, B., Spicer, T., Kairaitis, L., Rangan, G., Harris, D. (2005). Partial depletion of macrophages by ED7 reduces renal injury in Adriamycin nephropathy. Nephrology, 10(5), 470-7. [More Information]
  • Harris, D., Rangan, G. (2005). Retardation of kidney failure -- applying principles to practice. Annals of the Academy of Medicine, Singapore (AAMS), 34(1), 16-23. [More Information]
  • Wavamunno, M., Harris, D. (2005). The need for early nephrology referral. Kidney International, 67(Supplement 94), S-128-S-132. [More Information]
  • Zhu, G., Li, R., Harris, D. (2005). The role of tubulointerstitial inflammation cells in Human IgA nephropathy. Chinese Journal of Nephrology, 21, 256-259.
  • Zheng, G., Wang, Y., Mahajan, D., Qin, X., Wang, Y., Wang, Y., Alexander, S., Harris, D. (2005). The role of tubulointerstitial inflammation. Kidney International, 67(S94), S96-S100. [More Information]

2004

  • McMahon, L., Roger, S., Levin, A., Clarkson, A., Disney, A., Harris, D., Hawley, C., Healy, H., Kerr, P., Lynn, K., et al (2004). Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease. Journal of the American Society of Nephrology, 15(6), 1640-1647.
  • Harris, D. (2004). Editorial. Nephrology, 9(1), 1-1.
  • Roger, S., McMahon, L., Clarkson, A., Disney, A., Harris, D., Hawley, C., Healy, H., Kerr, P., Lynn, K., Parnham, A., et al (2004). Effects Of Early And Late Intervention With Epoetin Alpha On Left Ventricular Mass Among Patients With Chronic Kidney Disease (Stage 3 Or 4): Results Of A Randomized Clinical Trial. Journal of the American Society of Nephrology, 15(1), 148-56.
  • Zheng, G., Harris, D. (2004). Plasmin in renal interstitial fibrosis: Innocent or guilty? Kidney International, 66(1), 455-456.
  • Wang, Y., Tay, Y., Harris, D. (2004). Proximal Tubule Cells Stimulated By Lipopolysaccharide Inhibit Macrophage Activation. Kidney International, 66(2), 655-62.
  • Sadlier, D., Connolly, S., Kieran, N., Roxburgh, S., Brazil, D., Kairaitis, L., Wang, Y., Harris, D., Doran, P., Brady, H. (2004). Sequential Extracellular Matrix-Focused And Baited-Global Cluster Analysis Of Serial Transcriptomic Profiles Identifies Candidate Modulators Of Renal Tubulointerstitial Fibrosis In Murine Adriamycin-Induced Nephropathy. Journal of Biological Chemistry, 279(28), 29670-80.
  • Cooper, B., Branley, P., Bulfone, L., Collins, J., Craig, J., Dempster, J., Fraenkel, M., Harris, A., Harris, D., Johnson, D., Pollock, C., Tiller, D., et al (2004). The Initiating Dialysis Early And Late (Ideal) Study: Study Rationale And Design. Peritoneal Dialysis International, 24(2), 176-181.

2003

  • Rangan, G., Harris, D. (2003). A blast from the mast? Kidney International, 64(3), 1134-1135.
  • Kairaitis, L., Wang, Y., Zheng, L., Tay, Y., Wang, Y., Harris, D. (2003). Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease. Kidney International, 64(4), 1265-1272.
  • Johnson, D., AGAR, J., Collins, J., Disney, A., Harris, D., Ibels, L., Irish, A., SALTISSI, D., Suranyi, M. (2003). Recommendations for the use of icodextrin in peritoneal dialysis patients. Nephrology, 8(1), 1-7.

2002

  • Harris, D., Collins, J., Disney, A., Hawley, C., Irish, A., Kerr, P., Makris, A., Lynn, K., Pollock, C., Roger, S., et al (2002). Darbepoetin alfa: A new erythropoietic drug for the treatment of renal anaemia. Nephrology, 7(6), S173-S180.
  • Wang, Y., Harris, D., Rangan, G. (2002). Dietary Quercetin Augments activator Protein-1 and Does Not Reduce Nuclear Factor-KB in the Renal Cortex of Rats with Established Chronic Glomerular Disease. Nephron Journals, 90(3), 313-319.
  • Thomas, M., Harris, D. (2002). Management of bacterial peritonitis and exit-site infections in continuous ambulatory peritoneal dialysis. Nephrology, 7(6), 267-271.
  • Thomas, M., Harris, D. (2002). Problems and advantages of continuous renal replacement therapy. Nephrology, 7(3), 110-114.
  • Thomas, M., Harris, D. (2002). Renal effects of cyclo-oxygenase-2 inhibition. Nephrology, 7(6), 281-286.
  • Wang, Y., Yi, S., Tay, Y., Feng, X., Kairaitis, L., Harris, D. (2002). Transfection of tubule cells with Fas ligand causes leukocyte apoptosis. Kidney International, 61(4), 1303-1311.

2001

  • Field, M., Pollock, C., Harris, D. (2001). The Renal System. United States: Elsevier - Health Sciences Division.

To update your profile click here. For support on your academic profile contact .